Literature DB >> 24510754

Characterization of GABA receptors.

S J Enna1, Kenneth E McCarson.   

Abstract

Described in this unit are ligand-binding assays for GABAA , GABAB , and the homomeric ρ GABAA (formerly GABAC ) receptor recognition sites in brain tissue. Although GABA binding sites are present in peripheral organs, most research is directed toward examining these receptors in the CNS. These assays may also be used to determine the affinity of an unlabeled compound for the GABA binding sites. Excluded from the unit are ligand-binding assays for other components of the GABAA receptor complex, such as the benzodiazepine or ion-channel binding sites.
Copyright © 2013 John Wiley & Sons, Inc.

Entities:  

Keywords:  CNS; baclofen; gamma amino butyric acid; ligand binding; muscimol; neurotransmitter

Mesh:

Substances:

Year:  2013        PMID: 24510754      PMCID: PMC3927317          DOI: 10.1002/0471141755.ph0107s63

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  17 in total

Review 1.  Specific GABA(A) circuits in brain development and therapy.

Authors:  H Möhler; J-M Fritschy; F Crestani; T Hensch; U Rudolph
Journal:  Biochem Pharmacol       Date:  2004-10-15       Impact factor: 5.858

2.  Muscimol binding in rat brain: association with synaptic GABA receptors.

Authors:  K Beaumont; W S Chilton; H I Yamamura; S J Enna
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

3.  Binding of [3H]alpha-dihydropicrotoxinin, a gamma-aminobutyric acid synaptic antagonist, to rat brain membranes.

Authors:  M K Ticku; M Ban; R W Olsen
Journal:  Mol Pharmacol       Date:  1978-05       Impact factor: 4.436

4.  Influences ions, enzymes, and detergents on gamma-aminobutyric acid-receptor binding in synaptic membranes of rat brain.

Authors:  S J Enna; S H Snyder
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

5.  Properties of gamma-aminobutyric acid receptor binding with (+)-[3H]bicuculline methiodide in rat cerebellum.

Authors:  H Möhler; T Okada
Journal:  Mol Pharmacol       Date:  1978-03       Impact factor: 4.436

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

Review 7.  Hooked on benzodiazepines: GABAA receptor subtypes and addiction.

Authors:  Kelly R Tan; Uwe Rudolph; Christian Lüscher
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

Review 8.  The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs.

Authors:  R W Olsen
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

9.  Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label.

Authors:  H Möhler; M K Battersby; J G Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Characterization of the binding of the GABA agonist [3H]piperidine-4-sulphonic acid to bovine brain synaptic membranes.

Authors:  P Krogsgaard-Larsen; A Snowman; S C Lummis; R W Olsen
Journal:  J Neurochem       Date:  1981-08       Impact factor: 5.372

View more
  3 in total

1.  Functional Significance of the Excitatory Effects of GABA in the Suprachiasmatic Nucleus.

Authors:  John K McNeill; James C Walton; H Elliott Albers
Journal:  J Biol Rhythms       Date:  2018-07-05       Impact factor: 3.182

Review 2.  The dynamics of GABA signaling: Revelations from the circadian pacemaker in the suprachiasmatic nucleus.

Authors:  H Elliott Albers; James C Walton; Karen L Gamble; John K McNeill; Daniel L Hummer
Journal:  Front Neuroendocrinol       Date:  2016-11-25       Impact factor: 8.606

3.  Evidence for Tonic Control by the GABAA Receptor of Extracellular D-Serine Concentrations in the Medial Prefrontal Cortex of Rodents.

Authors:  Asami Umino; Sayuri Ishiwata; Hisayuki Iwama; Toru Nishikawa
Journal:  Front Mol Neurosci       Date:  2017-08-02       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.